In this session we will highlight some of Agilent’s latest developments in workflow solutions for the biopharmaceutical industry. These workflow will help you to implement end-to-end solutions for the analysis of oligonucleotides, antibodies and other new modalities including hard-and software as well as consumables and application support offerings.
